Amphastar Stock Pre-Market (-15%): Q4 Earnings and Revenue Miss

AMPH: Amphastar Pharmaceuticals logo
AMPH
Amphastar Pharmaceuticals

Amphastar is trading sharply lower after a significant Q4 earnings miss. The company fell short on both revenue and EPS, citing margin pressures. The weak forward guidance is overshadowing any pipeline optimism. Can the bulls defend the gap down, or is this the start of a new downtrend?

This is a structural catalyst. The earnings miss is not a one-off but reflects fundamental headwinds. The company reported Q4 EPS of $0.73, well below consensus estimates of ~$0.91, on revenues that also fell short.

  • Full-year 2025 revenue and adjusted EPS both declined year-over-year, reversing a multi-year growth trend.
  • Management guided to lower gross margins in 2026 due to pricing pressure and higher input costs.
  • The negative results from legacy products are currently outweighing the potential of the future pipeline.

But here is the interesting part. You are reading about this -15% move after it happened. The market has already priced in the news. To avoid the next loser before the headlines, you need predictive signals, not notifications. High Quality Portfolio has a risk model designed to reduce exposure to losers.


 

Relevant Articles
  1. MA Stock: The Math Behind The Upside
  2. Markets Don’t Lie: The Hidden Risk Priced Into GLW Right Now
  3. The Smart Way to Own TER: Collect 12% Before You Even Buy
  4. Structural Risks to Watch For NVDA Stock Over the Next 6 Months
  5. What Could Set Broadcom Stock on Fire
  6. What Is Happening With Advanced Micro Devices Stock?

Trefis: AMPH Stock Insights

Playbook On Market Open

The trading session will be a battle between the stark reality of the earnings print and management’s narrative about a long-term pipeline transition. Watch for analyst revisions to confirm sentiment.

  • Key resistance at $25.00 for any bullish reversal.
  • Watch pre-market lows for breakdown, confirming bearish trend.
  • The $24.00 pivot level will dictate short-term direction.

Verdict

FADE THE GAP: If the price holds above $24.00, a relief bounce is possible in the first 30 minutes. If it breaks and holds below, we expect a fade towards its 52-week lows.
Understanding price behavior can give you an edge. See more.


Want to make sure you never miss the explainer on AMPH’s next move? Stay updated with Upcoming Events and Latest Analyses


That’s for now, but so much more goes into evaluating a stock from a long-term investment perspective. We make it easy with our Investment Highlights

Portfolios Over Individual Stock Picks

Individual stocks can soar or tank, but one thing matters: staying invested. The right portfolio can help you stay invested, capture upside, and mitigate the downside associated with any individual stock.

Why settle for average market returns? The Trefis High Quality (HQ) Portfolio invests in a diverse group of 30 stocks that have collectively delivered stronger upside with reduced volatility compared to the broader indices. Discover the methodology behind these smoother, higher returns by checking the HQ Portfolio performance data.